About GeneChem
GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem Therapeutics Venture Fund L.P.. With committed capital of $136.5 million, the Therapeutics Fund's objectives were to invest within the genomics industry but specifically in companies developing therapeutics for proliferative disorders including cancer, infectious diseases, inflammation and diabetes.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Genetics, AI/ML, Climate
Investor Type
Venture Capital
Investment Focus
Focus Areas
Investment Stages